Enargan, John Ezra Earl C.

HRN: 28-56-80  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2026
CEFUROXIME 1.5GM (VIAL)
02/16/2026
02/23/2026
IV
1.5gms
Q8
Lacerated Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: